1. Home
  2. MRNA vs KSPI Comparison

MRNA vs KSPI Comparison

Compare MRNA & KSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • KSPI
  • Stock Information
  • Founded
  • MRNA 2010
  • KSPI 2008
  • Country
  • MRNA United States
  • KSPI Kazakhstan
  • Employees
  • MRNA N/A
  • KSPI N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • KSPI
  • Sector
  • MRNA Health Care
  • KSPI
  • Exchange
  • MRNA Nasdaq
  • KSPI Nasdaq
  • Market Cap
  • MRNA 16.0B
  • KSPI 16.8B
  • IPO Year
  • MRNA 2018
  • KSPI 2024
  • Fundamental
  • Price
  • MRNA $24.72
  • KSPI $85.58
  • Analyst Decision
  • MRNA Hold
  • KSPI Strong Buy
  • Analyst Count
  • MRNA 20
  • KSPI 2
  • Target Price
  • MRNA $54.47
  • KSPI $138.50
  • AVG Volume (30 Days)
  • MRNA 10.2M
  • KSPI 330.5K
  • Earning Date
  • MRNA 05-01-2025
  • KSPI 05-12-2025
  • Dividend Yield
  • MRNA N/A
  • KSPI 6.33%
  • EPS Growth
  • MRNA N/A
  • KSPI 23.97
  • EPS
  • MRNA N/A
  • KSPI 10.35
  • Revenue
  • MRNA $3,236,000,000.00
  • KSPI $4,849,581,791.00
  • Revenue This Year
  • MRNA N/A
  • KSPI $11.49
  • Revenue Next Year
  • MRNA $22.07
  • KSPI $19.86
  • P/E Ratio
  • MRNA N/A
  • KSPI $8.27
  • Revenue Growth
  • MRNA N/A
  • KSPI 33.72
  • 52 Week Low
  • MRNA $23.15
  • KSPI $77.80
  • 52 Week High
  • MRNA $170.47
  • KSPI $143.72
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 36.68
  • KSPI 42.17
  • Support Level
  • MRNA $23.68
  • KSPI $82.10
  • Resistance Level
  • MRNA $27.21
  • KSPI $88.00
  • Average True Range (ATR)
  • MRNA 2.06
  • KSPI 4.24
  • MACD
  • MRNA -0.03
  • KSPI -0.10
  • Stochastic Oscillator
  • MRNA 26.98
  • KSPI 45.02

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About KSPI Joint Stock Company Kaspi.kz

Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform that connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.

Share on Social Networks: